Market access, HEOR, and BD teams working to a date someone else set

A P&T meeting, an HTA submission, a label negotiation, a transaction closing. NextConsensus rebuilds the evidence record behind your claims and registers the probability that the regulator, guideline body, or payer you're waiting on acts by your date.

Questions for your next review

Market access and regulatory

  • Which guideline recommendations changed before our next coverage review?
  • Could new trial results lead payers to tighten step-therapy requirements?

Update your payer evidence package and advisory-board briefings before the review. Check the payer's procedures for reconsideration or appeal if the policy has already been published.

Playbook: taking a claim into a coverage or P&T review

HEOR and medical affairs

  • Which product claims are vulnerable to guideline downgrades?
  • Where does the real-world evidence say something different from the pivotal trial?

Prioritize real-world evidence and subgroup analyses for documented gaps in support before the next guideline review.

Playbook: when the guideline or label behind your claim moves

Business development and transactions

  • Which guideline, label, or coverage assumptions in the deal model remain uncertain?
  • Are the claims that justify peak sales projections supported by current evidence?

Price the transaction on a dated, checkable record of the asset's claims, and on the probability that the regulator, guideline body, or payer you are waiting on acts before close.

Royalty, credit, and valuation diligence

  • Which approval, label, or guideline assumptions in the valuation or royalty model are most exposed to a change?
  • How would a delayed or narrowed approval move the milestone or royalty schedule?

Stress-test the milestone, royalty, or credit model against a dated record of the claims it rests on, and against the probability that the regulator or guideline body acts by the date the model assumes.

Plan backward from the review date

Adapt these steps to your review calendar and the evidence behind your claim.

A year out Evidence gaps
  • Direct RWE studies to documented evidence gaps
  • Brief KOLs before guideline drafting opens
Six months out Dossier and committee prep
  • Answer the contested claims in the P&T dossier
  • Brief regional teams on differences between current recommendations and coverage policies
Three months out Rapid response
  • Submit payer evidence packages with dated sources
  • Draft field responses for the contested claims only
Decision day Published decision
  • Check the published wording and its effective date
  • Confirm whether a consultation, reconsideration, appeal, or later review is available

If the decision comes earlier or later

An earlier action pulls your calendar forward. A later one leaves time to resequence dependent work or close a specific evidence gap. Each team's playbook writes out both branches in the planning guides.